Peptide Therapeutics Sales to Triple by 2034
The peptide therapeutics market is witnessing significant transformation, driven by advances in biotechnology and a rising demand for innovative treatment options. Peptides, which are short chains of amino acids, play a crucial role in regulating various biological functions. Their therapeutic potential has gained immense traction in the pharmaceutical industry due to their high specificity, low toxicity, and ability to target a wide range of diseases. As healthcare systems evolve toward personalized and targeted medicine, the peptide therapeutics market is increasingly becoming a core focus for drug development pipelines across the globe. The global sales of peptide therapeutics is estimated to be worth USD 42.1 billion in 2024 and anticipated to reach a value of USD 117.4 billion by 2034. Sales are projected to grow at a CAGR of 10.8% over the forecast period between 2024 and 2034. The revenue generated by peptide therapeutics in 2023 was USD 38.0 billion. These therapies are fi...